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providing SQ-LNS on the iodine status of young Burkinabe chil-
dren.3 In Burkina Faso, salt iodization has been mandatory since 
2003. The regulations require an iodine content of 50–80  ppm 
at time of importation and > 30 ppm at retail distribution sites.4 
Thus, children in the study were also potentially exposed to io-
dized salt. At the time of the study, the latest national assess-
ment dated from 2003 indicated that only 34% of households 
consumed iodized salt with > 15 ppm iodine. 
“ In countries with  
inadequate salt iodization,  
other iodine interventions  
should be considered”
Methods
This study was an add-on study to the iLiNS-ZINC trial, which 
was a partially masked, placebo-controlled, cluster-randomized 
intervention study conducted in 34 communities of the Dandé 
Health District in southwestern Burkina Faso.5 Based on select-
ed indicators, 25 communities were assigned to participate in 
the intervention cohort (IC) and 9 communities were assigned 
to the non-intervention cohort (NIC). Within the IC, 9-month-
old children meeting the inclusion criteria received 20 g SQ-LNS 
daily containing different amounts of zinc from 9 to 18 months 
of age.3 Two of the four intervention groups participated in the 
iodine assessment: 1) SQ-LNS without zinc (LNS-Zn0) and 2) 
SQ-LNS with 10 mg zinc (LNS-Zn10). Children in all of the inter-
vention groups also received free treatment for diarrhea, malar-
Strategies to prevent iodine deficiency
Iodine is essential for human health, and particularly for infant 
and young child development, because of its key role as a struc-
tural element of thyroid hormones. Salt iodization is the most 
cost-effective strategy to prevent iodine deficiency, and its cov-
erage has increased substantially in recent decades.1 However, 
in countries with inadequate or unstable coverage of universal 
salt iodization, other supplementary iodine interventions should 
be considered for young children and pregnant women while ef-
forts are made to improve the coverage of the salt iodization 
program.2 These alternative intervention strategies can include 
iodine-fortified complementary foods or point-of-use fortificants, 
such as micronutrient powders (MNP) and small-quantity lipid- 
based nutrient supplements (SQ-LNS). 
 The present article summarizes a study published in the Brit-
ish Journal of Nutrition, which aimed to assess the impact of 
A study participant with her mother receiving  
a weekly ration of SQ-LNS.
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ia and fever, as described in more detail elsewhere.3 Children in 
the NIC did not receive SQ-LNS, morbidity surveillance, or any 
illness treatment during the study period.
 At enrollment, children were examined for eligibility to par-
ticipate in the iLiNS-ZINC trial.5 In a randomly selected subgroup 
of eligible children, a venous blood sample and a spot urine 
sample were collected at baseline and at the end of the study. 
Children who successfully provided a blood or urine sample at 
both 9 and 18 months of age were included in the present iodine 
analysis. Whole blood was preserved on dried blood spots, and 
plasma was aliquoted. Children’s iodine status was assessed 
based on: urinary iodine (UI), whole blood thyroid-stimulating 
hormone (TSH) and total thyroxin (T4), and plasma thyroglobulin 
(Tg) concentrations. Inadequate iodine status was defined as: 
UI < 100 µg/L.6 Normal reference ranges for TSH and T4 were 
0.1–3.7 mU/L and 65–165 nmol/L, respectively. A recommended 
normal range for Tg assessed in dried blood spots is available 
only for school-age children (4–40 µg/L), but not for young chil-
dren.7 Salt samples (n=106) were collected in the households of 
randomly selected study participants for assessment of iodine 
content by iodometric titration.
Results and conclusions 
A total of 3,220 children were enrolled in the iLiNS-ZINC trial, 
and a subset of 284 children provided blood and/or urine sam-
ples for the iodine assessment. At enrollment, children were 9.5 
± 0.3 months of age, and all children were still breastfed. Breast-
feeding continued to be very common; at 18 months of age, 97% 
of participating children were still breastfed. In contrast, com-
plementary feeding practices were suboptimal. At nine months 
of age, only 24% of children had consumed the minimum rec-
ommended number of meals during the previous 24 hours, and 
only 15% met the minimum food group diversity recommended 
by the World Health Organization.8 Although there was some im-
provement by 18 months of age, complementary feeding practic-
es remained suboptimal, with only 60% of children consuming 
the recommended minimum number of meals, and 27% meeting 
the minimum food group diversity.  
    The household salt samples (n=106) had a mean iodine content 
of 37 ppm, ranging from 5–86 ppm. Thirty-seven percent of the 
samples had an iodine content < 30 ppm, below the minimum lev-
el required at the retail level in Burkina Faso. Thus, the majority 
of households (63%) had adequately iodized salt available. 
 The iodine status results did not significantly differ between 
the intervention groups (LNS-Zn0 vs. LNS-Zn10), but there were 
some significant differences between children in the IC versus 
NIC. Tg concentrations were significantly higher in the NIC at 
baseline compared to IC (geometric mean (95% confidence in-
terval [CI]):  33.2 (28.8, 37.9) µg/L in NIC versus 27.5 (25.2, 29.9) 
µg/L in IC (p=0.005)). However, Tg concentrations were no lon-
ger significantly different between the cohorts after nine months 
of study intervention. Because there are no reference values for 
plasma Tg concentrations in young infants, differences between 
the cohorts was explored based on the upper and lower 2.5th per-
centile at 18 months, adjusted for the baseline value. Significant-
ly more children in the NIC (n=5; 6%) had low adjusted Tg (< 10.6 
µg/L) compared to children in IC (n=1; 0.6%; p=0.006). 
 Baseline UI concentration did not differ significantly; the geo-
metric mean (95% CI) was 220 (192, 257) µg/L in children in IC 
and 276 (192, 397) µg/L in children in NIC. After nine months of 
intervention, the UI concentration was also not significantly dif-
ferent, and only 4% of children in the IC and 5% in the NIC had 
low UI concentration (p=0.906). 
 There was no significant difference in TSH or T4 concentrations 
between the cohorts at baseline and at endline. Only one child 
had elevated TSH concentration at baseline, and all children had 
normal TSH concentrations at the end of the study. The prevalence 
of low T4 concentration was low at 9 and 18 months of age in both 
cohorts. However, there was a marginally significant difference in 
hypothyroxinemia at 18 months of age (p=0.052). Namely, fewer 
children (n=2; 1.6%) in the IC had abnormally low T4 concentra-
tions at the end of the study than in the NIC (n=5; 8.9%).  
 In summary, although there were some small differences in 
low T4 and Tg concentrations between the IC and NIC cohorts 
after nine months of intervention, the vast majority of all chil-
dren participating in the study had adequate iodine status and 
normal thyroid hormone concentrations. These results sug-
gest that these young study participants consumed sufficient 
amounts of iodine either through breast milk or from iodized 
salt in family food. 
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“ Study participants consumed  
sufficient iodine either through  
breast milk or from iodized salt”
 The World Health Organization, the International Council for 
the Control of Iodine Deficiency Disorders and UNICEF recom-
mend an intake of 90 µg iodine/day for children < 60 months of 
age.9 Dietary intake was not quantitatively assessed in the study. 
However, considering the high frequency of continued breast-
feeding reported in the study participants, children could have 
consumed 80–90 µg iodine per day through breast milk alone, 
and most were also consuming at least some complementary 
foods that contained iodized salt.3 Thus, a provision of 90 µg 
of iodine in SQ-LNS may have been too high, and could have put 
some children at risk of usual intakes above the Tolerable Upper 
Intake Level (UL). The UL is the highest average usual iodine 
intake that is likely to not pose adverse health risks, and is set at 
200 µg iodine per day for children 1–3 years of age.10,11 Because 
there is not yet consensus on the appropriate cut-off to indicate 
elevated UI among young children, we are not able to judge the 
risk associated with the observed UI levels. However, consider-
ing that almost all children in the IC had normal thyroid hormone 
concentrations, the dietary iodine intakes among IC children did 
not seem to pose adverse health risks. 
 In conclusion, a reduction of SQ-LNS iodine content should 
be considered in settings with similarly successful salt iodiza-
tion programs and high rates of continued breastfeeding. As-
sessment of the iodine status of the target population should 
be considered prior to distributing home fortification products 
such as SQ-LNS and MNP. Additional research on the impact of 
SQ-LNS on children’s iodine status is needed in countries with 
lower or unstable coverage of the salt iodization program.
“ A reduction in SQ-LNS iodine  
content should be considered in  
settings with successful salt  
iodization programs and high  
breastfeeding rates”
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